You have 5 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

SY-4835

Showing 26 - 49 of 49
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Non-Cystic Fibrosis Bronchiectasis Trial in Worldwide (Brensocatib 10 mg, Brensocatib 25 mg, Placebo)

Recruiting
  • Non-Cystic Fibrosis Bronchiectasis
  • Brensocatib 10 mg
  • +2 more
  • Birmingham, Alabama
  • +416 more
Jan 24, 2023

Cerebral Apoplexy Trial in Chendu (SY-007)

Completed
  • Cerebral Apoplexy
  • Chendu, Sichuan, China
    West China Hospital of Sichuan University
Apr 30, 2021

Alzheimer, Mild Cognitive Impairment, Metabolic Syndrome Trial in Ramat Gan (Semaglutide, Intranasal insulin, Semaglutide )

Not yet recruiting
  • Alzheimer Disease
  • +2 more
  • Ramat Gan, Israel
    Joseph Sagol Neuroscience center, Sheba Medical Center
Oct 3, 2023

Non-alcoholic Steatohepatitis Trial in Worldwide (Semaglutide, Placebo)

Recruiting
  • Non-alcoholic Steatohepatitis
  • Huntsville, Alabama
  • +369 more
Nov 23, 2022

Early Alzheimer's Disease Trial in Worldwide (Semagludtide, Placebo (semaglutide))

Recruiting
  • Early Alzheimer's Disease
  • Phoenix, Arizona
  • +332 more
Mar 30, 2022

Multiple Sclerosis Trial in Worldwide (dimethyl fumarate)

Active, not recruiting
  • Multiple Sclerosis
  • dimethyl fumarate
  • Birmingham, Alabama
  • +467 more
Jun 23, 2022

Sepsis Trial in Nanjing (SY-005)

Completed
  • Sepsis
  • Nanjing, Jiangsu, China
    Jiangsu Province Hospital
May 31, 2021

Type 2 Diabetes Trial in Beijing (SY-004, SY-004 matching )

Recruiting
  • Type 2 Diabetes Mellitus
  • Beijing, Beijing, China
    PLA General Hospital
May 15, 2021

Early Alzheimer´s Disease Trial in Worldwide (Semaglutide, Placebo (semaglutide))

Recruiting
  • Early Alzheimer´s Disease
  • Phoenix, Arizona
  • +351 more
Mar 29, 2022

Cardiovascular Disease and Lipoprotein(a) Trial in Worldwide (TQJ230, Placebo)

Active, not recruiting
  • Cardiovascular Disease and Lipoprotein(a)
  • Andalusia, Alabama
  • +791 more
Oct 7, 2022

Ulcerative Colitis Trial in Worldwide (Ontamalimab, Placebo)

Completed
Has Results
  • Ulcerative Colitis
  • Mesa, Arizona
  • +400 more
Dec 16, 2021

Crohn Disease Trial in Worldwide (Ozanimod)

Recruiting
  • Crohn Disease
  • Peoria, Arizona
  • +1232 more
Jan 9, 2023

Coronary Heart Disease (CHD) Trial in Worldwide (Evolocumab, Placebo)

Active, not recruiting
  • Coronary Heart Disease (CHD)
  • Athens, Alabama
  • +851 more
Dec 19, 2022

Crohn Disease Trial in Worldwide (Ozanimod, Placebo)

Recruiting
  • Crohn Disease
  • Peoria, Arizona
  • +709 more
Jul 22, 2022

Diabetes Trial in Nanjing (SY-008)

Completed
  • Diabetes
  • Nanjing, Jiangsu, China
    The First Affiliated Hospital of Nanjing Medical University
Oct 8, 2019

Diabetes Trial in Beijing (SY-009)

Completed
  • Diabetes
  • Beijing, Beijing, China
    China-Japan Friendship Hospital
Oct 8, 2019

Alzheimer Trial in Worldwide (Placebo, BI 409306, Donepezil)

Completed
Has Results
  • Alzheimer Disease
  • Placebo
  • +2 more
  • Sherman Oaks, California
  • +59 more
Oct 18, 2018

Heart Failure Trial in Worldwide (Omecamtiv Mecarbil, Placebo, Standard of Care)

Completed
Has Results
  • Heart Failure
  • Omecamtiv Mecarbil
  • +2 more
  • Birmingham, Alabama
  • +1033 more
Nov 2, 2021

Acute Coronary Syndromes Trial in Worldwide (Apixaban, vitamin K antagonist, Acetylsalicylic acid)

Completed
Has Results
  • Acute Coronary Syndromes
  • Birmingham, Alabama
  • +625 more
Jun 9, 2020

Crohn's Disease Trial in Worldwide (GED-0301, Placebo)

Terminated
Has Results
  • Crohn's Disease
  • San Diego, California
  • +230 more
Jan 28, 2019

Crohn Disease Trial in Worldwide (GED-0301, Placebo)

Terminated
Has Results
  • Crohn Disease
  • Huntsville, Alabama
  • +537 more
Aug 20, 2019

Chronic Heart Failure With Reduced Ejection Fraction Trial in Worldwide (LCZ696)

Completed
Has Results
  • Chronic Heart Failure With Reduced Ejection Fraction
  • Huntsville, Alabama
  • +396 more
Feb 19, 2019

COPD Trial in Worldwide (Glycopyrronium, SABA, LABA)

Completed
Has Results
  • COPD
  • Amstetten, Austria
  • +543 more
Mar 18, 2019

Venous Thromboembolism, Cancer Trial in Worldwide (Semuloparin sodium, Placebo (for semuloparin))

Completed
  • Venous Thromboembolism
  • Cancer
  • Semuloparin sodium
  • Placebo (for semuloparin)
  • Birmingham, Alabama
  • +410 more
Jan 14, 2013